Image courtesy of Pixabay
The pandemic continued to remake the pharma and biotech industry this past year. A handful of companies fared exceptionally well at commercializing COVID-19 therapies. This fact promises to lead to sizable shifts in the rankings of pharma leaders. These trends were not yet evident in our spring roundup of the 50 largest pharma companies, which drew revenue figures from the prior year. But in 2021, companies like Pfizer and Moderna sold tens of billions of dollars of COVID-19 vaccine alone. As a result of the ongoing pandemic, significant shifts are likely in 2022’s forthcoming ranking of pharma leaders.
Here, we provide an opportunity to review the 2021 pharma landscape, including stories that received the most attention on social media.
1. Pharma 50: The 50 largest pharmaceutical companies in the worldThe top 50 largest pharmaceutical companies raked in $851 billion…